Press Release: Vedanta : Vedanta Biosciences to Host Investor Meetings at the Leerink Partners 2024 Global Biopharma Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that management will host investor meetings at the Leerink Partners 2024 Global Biopharma Conference being held in Miami, FL from Monday, March 11 through Wednesday, March 13, 2024. About Vedanta Biosciences Vedanta Biosciences is leading the development of a potential new category of oral therapies b